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ABSTRACT. Hypertension has become the third highest cause of death in Indonesia. The condition is 
correlated with angiotensin-converting enzyme (ACE), and possibly managed with the use of drugs. In 
addition, some natural compounds, including 6-shogaol and 6-gingerol from ginger, are used to decrease 
blood pressure. However, the mechanism and binding site of these compounds to ACE protein is currently 
unclear. This study, therefore, aims to investigate the potential role of these compounds as an angiotensin-
converting enzyme inhibitor. The ACE protein was downloaded from Protein Data Bank (PDB) database 
with the ID: 3bkk, while the 6-shogaol (CID: 5281794) and 6-gingerol (CID: 44559528) ligands were 
obtained from the PubChem database. Meanwhile, molecular docking was established using HEX 8.0.0 
software. The analysis examined the amino acid residues and the bonds formed from these interactions. 
According to the results, 14 amino acid residues were formed by the interaction between 6-shogaol and 
ACE, while the interaction between 6-gingerol and ACE formed eight amino acids. Also, 13 amino acid 
residues in the novelty binding site of ACE were discovered to be blocked by the ligands from ginger. 
Therefore, the compounds have potential roles as inhibitors, and this possibly helps to prevent regulation 
of the renin-angiotensin system. These interactions also formed hydrogen bonds, as well as electrostatic, 
unfavorable, and hydrophobic sites, making the binding stronger than others.   
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INTRODUCTION 
Type 2 Diabetes Mellitus (T2DM) is a 
metabolic disease characterized by insulin 
resistance, hyperglycemia, and pancreatic β-
cell dysfunction (Ashcroft & Rorsman, 2012; 
Hameed et al., 2015; Bare et al., 2018). The 
World Health Organization (WHO) predicts 
T2DM prevalence to have increased in 
Indonesia by 2030. According to Tarigan et al. 
(2018), the condition is closely related to 
hypertension, the third highest cause of death 
within the country. Hypertension is related to 
the Angiotensin-converting enzyme (ACE), 
and this protein hydrolyzes and converts 
inactive angiotensin-I to active angiotensin-II 
(Ouwerkerk et al., 2017; Messerli et al., 2018). 
Synthetic drugs are able to maintain 
hypertension by reducing blood pressure. 
However, these drugs tend to have side effects. 
Therefore, the accuracy of drugs ought to be 
evaluated in order to achieve the therapeutic 
goals, as redactors of cardiovascular morbidity 
and mortality. The administration of 
inappropriate antihypertensive medicine tends 
to increase blood pressure and lead to heart 
attack, stroke, kidney disease, as well as other 
ailments. Traditional treatment using natural 
herbs has provided an effective alternative for 
reducing blood pressure. The bioactive 
compounds in herbs are less toxic compared to 
synthetic drugs. Furthermore, natural medicine 
helps to exploit biological resources (Chiou et 
al., 2017; Kesuma et al., 2018). Various natural 
compounds have been reported as ACE 
inhibitors. These include quercetin (Larson et 
al., 2010; Muhammad & Fatima, 2015; Liu et 
al., 2020), chlorogenic acid (Agunloye & 
Oboh, 2018; Bare et al., 2019a), hyperin 
(Huang et al., 2017), tannic acid, flavonoid, and 
phenolic compounds (Nileeka-Balasuriya & 
Vasantha-Rupasinghe, 2011; Al Shukor et al., 
2013). 
Ginger (Zingiber officinale) is one of the 
natural herbs to reduce blood pressure. In 
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Sikka, ginger is used to treat skin disease, 
strokes, hypertension, and diabetes mellitus. 
The herb also contains 6-gingerol, 6-shogaol, 8-
gingerol, 8-shogaol, 10-gingerol, and 10-
shogaol and other polyphenols (Mao et al., 
2019) with anti-diabetic (Shivanna  et al., 
2013), anti-hypertensive property (Akinyemi et 
al., 2013; Bare et al., 2019b). According to the 
in-vitro study, ginger extract prevents 
hypertension and manages blood pressure 
(Akinyemi et al., 2013). Furthermore, the herb 
contains bioactive compounds with 
antagonistic effects on ACE-1 (Liu et al., 2013; 
Zhao et al., 2018; Bare et al., 2019b). However, 
the inhibition mechanism of these compounds 
on ACE is not currently clear. Therefore, this 
study analyzed the bioactive compounds in 
ginger as appropriate nutrients for treating 
genomic hypertension through ACE inhibition. 
 
MATERIALS AND METHODS 
Ligand and Protein Preparation. The 
model ACE (ID: 3bkk) was obtained from the 
Protein Data Bank (PDB) database 
http://www.rcsb.org/pdb/home/home.do, while 
the 6-shogaol ligand (CID: 5281794) and 6-
gingerol (CID: 44559528) were acquired from 
the PubChem database. Subsequently, the 
energy of these ligands were minimized using 
the PyRx virtual screening program Open 
Babel tool and converted from SDF into PDB 
files. The protein obtained were then cleaned to 
extract water molecules and binding ligands, 
using Discovery Studio Client 4.1 (Bare et al., 
2019a). 
Molecular Interaction. HEX 8.0.0 
software was used to dock the prepared protein 
and ligand. The docking parameters utilized 
were Shape, electro and DARS. Subsequently, 
the protein-ligand’s 3D model, ACE binding 
sites, interaction types, and Ramachandran plot 
were determined and visualized using 
Discovery Studio Client 4.1 software (Bare et 
al., 2019b).  
 
RESULTS AND DISCUSSION 
The interaction between 6-gingerol and 
ACE was discovered to occur in eight amino 
acid residues active sites. Fig. 1c and Fig. 1d 
show amino acid residues involved in this 
interaction, TYR253, HIS383, HIS387, 



















































Fig. 1. The Interactions between ACE and 6-gingerol: a. 
6-Gingerol bonding area in ACE; b. Ramachandran plot 
complex 6-gingerol-ACE; c. 3D active side ACE against 
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The types of bond discovered between the 
ligand and protein were Pi-Alkyl (TYR253, 
HIS383, HIS387), Pi-Anion (ASP377), 
unfavourable bump (ALA354, GLU162), 
carbon hydrogen bond (ASN167) and 
convention hydrogen bond (GLU376). 
According to Table 1, the binding energy of the 



































Fig. 2. The physicochemical complex of ACE-6-gingerol:  a. hydrophobicity, and ACE-6 gingerol hydrophobicity plot; 
b. hydrogen bond and hydrogen bond plot ACE-6 gingerol; c. active side load of ACE-6 gingerol;  d. ionization;  e. 
solvent accessible surface (SAS). 
 































454.176 Electrostatic Pi-Anion Negative Pi-Orbitals 
A:HIS383 - :LIG1:C 408.155 Hydrophobic Pi-Alkyl Pi-Orbitals Alkyl 
A:HIS387 - :LIG1:C 497.361 Hydrophobic Pi-Alkyl Pi-Orbitals Alkyl 
A:TYR523 - :LIG1:C 49.363 Hydrophobic Pi-Alkyl Pi-Orbitals Alkyl 
A:ALA354:N - 
:LIG1:H 
18.073 Unfavorable Unfavorable 
Bump 
Steric Steric 
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A:ALA354:HN - 
:LIG1:O 

















-256.6 A:LYS454:NZ - 
:LIG1:O 

































































448.191 Electrostatic Attractive 
Charge 
Positive Negative 
A:ZN701:ZN - :LIG1:O 490.198 Electrostatic Attractive 
Charge 
Positive Negative 



















:LIG1:O - A:HIS383 240.757 Electrostatic Pi-Anion Negative Pi-Orbitals 
:LIG1:C - A:PHE457 371.723 Electrostatic Pi-Anion Negative Pi-Orbitals 
:LIG1:C - :LIG1 437.364 Electrostatic Pi-Anion Negative Pi-Orbitals 
:LIG1:C - A:TYR523 425.252 Electrostatic Pi-Anion Negative Pi-Orbitals 
:LIG1:C - A:HIS383 414.965 Electrostatic Pi-Anion Negative Pi-Orbitals 
:LIG1:C - A:HIS383 470.278 Electrostatic Pi-Anion Negative Pi-Orbitals 
:LIG1:C - :LIG1 46.581 Electrostatic Pi-Anion Negative Pi-Orbitals 
:LIG1:C - :LIG1 482.374 Electrostatic Pi-Anion Negative Pi-Orbitals 
:LIG1:C - A:HIS383 340.722 Electrostatic Pi-Anion Negative Pi-Orbitals 
:LIG1:C - A:HIS383 441.211 Electrostatic Pi-Anion Negative Pi-Orbitals 
A:VAL379:CG1 - 
:LIG1 
372.681 Hydrophobic Pi-Sigma C-H Pi-Orbitals 
A:GLN281:NE2 - 
:LIG1:C 










140.403 Unfavorable Unfavorable 
Bump 
Steric Steric 
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A:LYS454:HZ3 - 
:LIG1:H 
211.853 Unfavorable Unfavorable 
Donor-Donor 
H-Donor H-Donor 
Based on Fig. 2a, the interaction between 
6-gingerol and ACE indicates low 
hydrophobicity on the surface of the ligand. 
Fig. 2b and Table 1 show the 6-gingerol 
compound also functions as a donor and 
acceptor of ACE in GLU376 and ASN167, 
while Fig. 2c and Fig. 2d indicate the 6-gingerol 
compound tends to be neutral, thus the ligand is 
zero charged. According to Fig. 2e, the value of 
the solvent-accessible surface (SAS) for 6-
gingerol surface is relatively high. SAS values 
are related to the van der Waals forces between 

































Fig. 3. The complex 6-shogaol-ACE:  a. 6-Shogaol-ACE bonding area; b. Ramachandran plot complex 6-shogaol-ACE; 
c. 3D active side 6-Shogaol-ACE; d. 2D active side 6-Shogaol-ACE. 
 
The 6-shogaol-ACE complex exhibited a 
potential mechanism to inactivate the ACE 
conformation. Fig. 3c and Fig. 3d show the 
complex’s active sites performing functional 
inhibition of ACE. These are GLU376 
(hydrogen Bond type Carbon hydrogen), 
LYS454, LYS511, ZN701 (electrostatic 
tractive charge), HIS383, PHE457, TYR523, 
HIS383 (electrostatic Pi-Anion), VAL379 
(hydrophobic Pi-Sigma), GLN281 
(unfavorable bump), GLU376, ASP145, 
ASP453 (unfavorable negative-negative), 
LYS454 (unfavorable donor-donor). 
Meanwhile, Table 1 shows the binding energy 
of 6-shogaol-ACE was -256.6 cal/mol. This is 
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Fig. 4. The physicochemical complex 6-shogaol-ACE: a. hydrophobicity and the 6-shogaol-ACE hydrophobicity plot; b. 
hydrogen bond and hydrogen bond plot 6-shogaol-ACE; c. 6-shogaol-ACE active side load; d. ionization. e. solvent 
accessible surface (SAS).   
 
Fig. 4a shows the low hydrophobicity level 
of 6-shogaol-ACE, denoted by blue color. 
Meanwhile Fig. 4b and Table 1 show a potential 
residue, GLU376 capable of functioning as an 
ACE donor or acceptor of ACE. Fig. 4c and Fig. 
4d show the 6-shogaol-ACE complex’s zero 
charge, denoted by brown color. Based on Fig. 
4e, the complex has a high solvent-accessible 
surface (SAS) value, depicted by green color.  
The interaction between 6-gingerol, 6-
shogaol, and ACE indicated positive results. 
According to Table 1, twenty amino acid 
residues performed as ACE active sites, leading 
ACE inactivation. A study by Ouwerkerk et al. 
(2017) stated several bioactive compounds 
significant for reducing the pathological impact 
on metabolism are currently being studied, 
while Al Shukor et al. (2013) reported 
molecular interactions between ACE inhibitors 
and the ACE binding site from plant phenolic 
compound in twelve amino acid residues. 
Similarly, 6 of these 12 amino acid residues 
were found to interact with the ligand in this 
study. These are TYR523, ALA354, LYS511, 
GLN281, ASP453, and ASP415. Meanwhile, 
Muhammad & Fatimah (2015) reported other 
amino acid residues capable of binding with 
quercetin glycosides. These are ARG124, 
TYR135, ILE204, ALA208, GLU216, 
TYR215, and GLU96. This study also 
discovered novel binding sites from amino acid 
residues interacting with 6-gingerol and 6-
shogaol. These are TYR253, HIS383, HIS387, 
ASP377, GLU162, ASN167, GLU376, ZN701, 
HIS383, PHE457, VAL379, ASP145, and 
LYS454, and these are different from the 
quercetin and phenolic compound binding sites. 
In addition, the presence of several hydrogen 
bonds in the ligand-protein complex suggested 
strong binding (Bare et al., 2019b) 
Candrakirana, 2019; Kataria & Khatkar, 2019).  
These bonds also promoted ligand binding 
affinities and stabilized the ligand-protein 
interaction (Zhou et al., 2012). The lower 
binding distance between ALA354 and 6-
gingerol leads to the formation of a stronger and 
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tighter hydrogen bond, compared to the others 
(Santoso et al., 2016).  
ACE inhibition is a critical stage of 
hypertension treatment because ACE has a 
crucial role in regulating the renin-angiotensin 
system (Guang et al., 2012; Liao et al., 2019). 
This method has a positive effect on therapy 
and has been linked to improved health, outside 
of blood pressure regulation (Bhullar et al., 
2014). Liu et al. (2013) reported 6-gingerol to 
be a molecular target drug for curving 
hypertension. This study also proposed the 
molecular interaction this compound and 
another amino acid residue. Meanwhile, 
Akinyemi et al. (2013) and Zhao et al. (2018) 
stated ginger varieties inhibited ACE and also 
protected the heart from Fe2+- and SNP-induced 
lipid peroxidation. Recent research also showed 
ginger extract influences blood pressure and 
lipid level in hypertensive and hyperlipidemic 
Wistar rats model (Sanghal et al., 2011, Sahardi 
& Makpol, 2019). Similarly, a study by 
Akinyemi et al. (2014) reported ginger extract 
to exhibit ACE inhibitory activity. The 
interaction between ligan and protein has a 
positive impact, as ACE inhibitor was produced 
by renin to convert angiotensin I into 
angiotensin II. Also, Sahardi & Makpol (2019), 
disclosed ginger is able to reduce the blood 
pressure of hypertension patients, as well as 
lipid peroxidation in the heart. 
 
CONCLUSION 
This study confirmed the binding of 6-
shogaol and 6-gingerol to ACE protein is tight, 
and the complex formed possibly has potential 
ACE inhibitory activity within ACE active 
sites. This interaction was observed to occur in 
twenty amino acid residues. The interaction 
also formed hydrogen bonds, electrostatic, 
unfavorable, and hydrophobic bonds, making 
binding stronger, compared to others. 
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